Category: Prescription Drugs
Prescription Drugs market research reports by Euromonitor International
-
Rx/Reimbursement Adult Incontinence in Denmark
Rx/Reimbursement Adult Incontinence in Denmark Noteworthy unit price increases in 2023 also affected Rx/Reimbursement adult incontinence in Denmark. Significant price increases were driven by cost inflation covering aspects like energy, material sourcing, labour, logistics and supply chain constrain ... Read More
-
Rx/Reimbursement Adult Incontinence in the Czech Republic
Rx/Reimbursement Adult Incontinence in the Czech Republic In 2023, Rx/reimbursement adult incontinence recorded moderate volume growth, resulting from growing consumer awareness not only of incontinence, but also from health insurance companies and their reimbursement payments to consumers for the c ... Read More
-
Rx/Reimbursement Adult Incontinence in France
Rx/Reimbursement Adult Incontinence in France Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first year ... Read More
-
Rx/Reimbursement Adult Incontinence in Colombia
Rx/Reimbursement Adult Incontinence in Colombia In 2023, incontinence Rx/Reimbursement recorded a rate that, although positive, has been the lowest since 2020. Even though these products are covered by MIPRES, a system in which physicians prescribe medicines, nutritional supplements, and diapers for ... Read More
-
Rx/Reimbursement Adult Incontinence in Belgium
Rx/Reimbursement Adult Incontinence in Belgium The year 2023 witnessed a notable increase in demand for RX/reimbursement adult incontinence products in Belgium, spurred by several key drivers. Firstly, Belgium's ageing population continued to fuel sustained demand for such products. Additionally, th ... Read More
-
Rx/Reimbursement Adult Incontinence in the US
Rx/Reimbursement Adult Incontinence in the US Rising consumer awareness around incontinence and proper condition management, partnerships with direct-to-consumer platforms and the expanding 65+ year-old population in the US all contributed to healthy value and volume growth in the Rx/reimbursement a ... Read More
-
Weight Loss Drugs and the Future of Weight Management and Wellbeing
Weight Loss Drugs and the Future of Weight Management and Wellbeing 2023 saw surging interest in weight loss driven by the rise of GLP-1 medications, with prescription drugs like Ozempic and Wegovy creating headlines during the year. Demand will continue to be strong in 2024, driven by the efficacy ... Read More
-
Rx/Reimbursement Adult Incontinence in Australia
Rx/Reimbursement Adult Incontinence in Australia The Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022 changed who can get payments under the Continence Aids Payment Scheme (CAPS) to avoid double-dipping. It means that care recipients who already receive continence products as p ... Read More
-
Rx/Reimbursement Adult Incontinence in Hong Kong, China
Rx/Reimbursement Adult Incontinence in Hong Kong, China In 2022, retail volume and value sales of rx/reimbursement adult incontinence remained insignificant in Hong Kong. The Comprehensive Social Security Assistance (CSSA) Scheme is primarily responsible for providing subsidies and reimbursements fo ... Read More
-
Haleon Plc in Consumer Health (World)
Haleon Plc in Consumer Health (World) After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa have provided s ... Read More
-
Pharmaceuticals and Medical Equipment in Asia Pacific
Pharmaceuticals and Medical Equipment in Asia Pacific In 2021, Asia Pacific ranked first globally in terms of production output of pharmaceuticals and medical equipment, with a turnover of USD857 billion. Over 2021-2030, the region is expected to record the fastest production growth globally, underp ... Read More
-
Rx/Reimbursement Adult Incontinence in Portugal
Rx/Reimbursement Adult Incontinence in Portugal PPI Euromonitor International's Rx/Reimbursement adult incontinence in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify t ... Read More
-
Rx/Reimbursement Adult Incontinence in Malaysia
Rx/Reimbursement Adult Incontinence in Malaysia There is no presence of Rx/reimbursement adult incontinence in Malaysia in 2021 and no indication that this will change in the forecast period. Euromonitor International's Rx/Reimbursement adult incontinence in Malaysia report offers a comprehensive g ... Read More